Apexigen | SPAC Presentation Deck | 28 slides · page 18 of 28
Apexigen | SPAC Presentation Deck | 28 slides · slide 18
Pitch deck · key_takeaways · summarize · balanced density
Slide locked Sign in to view
Slide schematic 4/4
list 3/3 title 1/1
Components 4
bullet bullet bullet headline
Tools 2
List presentation slide · 80%
list/bullet: Sotigalimab is Potentially the First-in-Class and Best-in-Class CD40 Agonist Antibody.
Storytelling: the three headline reasons slide · 50%list/bullet: Therapeutic Effect Observed in Several Indications. list/bullet: Multiple Upcoming Phase 2 Data Readouts.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.